Showing results (101-110 of 1,358) with videos related to
Sort By:
Pageof 136
Tumori|December 31, 1990
Primary chemotherapy and delayed surgery for malignant fibrous histiocytoma of bone in the extremityG Bacci, M Avella, P Picci, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bonesG Bacci, P Picci, S Ferrari, et al.Italian Journal of Orthopaedics and Traumatology|December 1, 1991
Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapyG Bacci, S Ferrari, M Avella, et al.Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.Cancer|January 15, 1997
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesionsG Bacci, M Mercuri, A Briccoli, et al.Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoliG Bacci, S Ferrari, F Bertoni, et al.Journal of Chemotherapy (Florence, Italy)|August 1, 1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studiesG Bacci, P Picci, P Ruggieri, et al.Acta Orthopaedica Scandinavica|August 14, 1998
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapyG Bacci, S Ferrari, M Mercuri, et al.La Chirurgia Degli Organi Di Movimento|June 12, 2002
Adjuvant and neoadjuvant chemotherapy in osteosarcomaG Bacci, S LariPageof 136